• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    1/7/22 10:39:09 AM ET
    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Aerospace
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACHR alert in real time by email

     

    Before 10 am on Friday, 110 companies set new 52-week lows.

    Interesting Points From Today's 52-Week Lows:

    • Humana (NYSE:HUM) was the biggest company on a market cap basis to set a new 52-week low.
    • Reshape Lifesciences (NASDAQ:RSLS) was the smallest firm on a market cap basis to set a new 52-week low.
    • Aligos Therapeutics (NASDAQ:ALGS)'s stock moved significantly downwards, trading down 46.75% to reach a new 52-week low.
    • Athenex (NASDAQ:ATNX) shares were the most resilient of the group, as shares actually moved up 0.0% in response to hitting its 52-week low.

    Stocks that set new 52-week lows during the first half-hour of trading on Friday are as follows:

    • Humana (NYSE:HUM) stock hit $352.38 on Friday morning, setting a new 52-week low for a change of down 3.19%.
    • CoStar Gr (NASDAQ:CSGP) stock dropped to a yearly low on Friday of $72.91. Shares traded down 0.99%.
    • Roku (NASDAQ:ROKU) stock hit a new 52-week low of $180.49. The stock was down 3.79% on the session.
    • DiDi Global (NYSE:DIDI) shares made a new 52-week low of $4.56 on Friday. The stock was down 1.49% for the day.
    • Chewy (NYSE:CHWY) stock hit a new 52-week low of $48.61. The stock was down 6.24% on the session.
    • Elanco Animal Health (NYSE:ELAN) stock broke to a new 52-week low of $26.86 on Friday. Shares of the company traded up 0.92%.
    • Cognex (NASDAQ:CGNX) shares fell to $71.38 on Friday, setting a new 52-week low with a shift of down 1.46%.
    • Aurora Innovation (NASDAQ:AUR) stock broke to a new 52-week low of $9.05 on Friday. Shares of the company traded down 3.55%.
    • Natera (NASDAQ:NTRA) stock achieved a new 52-week low on Friday morning, hitting $80.02 and moving down 1.84%.
    • Oak Street Health (NYSE:OSH) shares were down 2.95% for the day, having made a 52-week low of $25.63.
    • Cazoo Gr (NYSE:CZOO) shares fell to $4.80 on Friday, setting a new 52-week low with a shift of down 0.6%.
    • Embark Technology (NASDAQ:EMBK) stock broke to a new 52-week low of $6.50 on Friday. Shares of the company traded down 1.69%.
    • Sendas Distribuidora (NYSE:ASAI) shares set a new 52-week low of $10.01. The stock traded down 1.37%.
    • Expensify (NASDAQ:EXFY) stock broke to a new 52-week low of $31.50 on Friday. Shares of the company traded down 5.12%.
    • Open Lending (NASDAQ:LPRO) shares set a new yearly low of $19.90 this morning. The stock was up 0.15% on the session.
    • Alignment Healthcare (NASDAQ:ALHC) shares reached a new 52-week low of $11.21 on Friday morning, moving down 1.53%.
    • Udemy (NASDAQ:UDMY) stock hit a new 52-week low of $14.47. The stock was down 2.2% on the session.
    • Mirion Technologies (NYSE:MIR) shares made a new 52-week low of $9.47 on Friday. The stock was down 2.54% for the day.
    • N-able (NYSE:NABL) stock hit $10.29 on Friday morning, setting a new 52-week low for a change of down 0.77%.
    • Clover Health Investments (NASDAQ:CLOV) stock hit a new 52-week low of $3.19. The stock was down 2.44% on the session.
    • Cano Health (NYSE:CANO) stock dropped to a yearly low on Friday of $7.82. Shares traded down 2.93%.
    • Nuvation Bio (NYSE:NUVB) shares moved down 2.23% on Friday to hit a new 52-week low of $6.45, drifting down 2.23%.
    • Doma Holdings (NYSE:DOMA) shares set a new yearly low of $4.28 this morning. The stock was up 0.46% on the session.
    • Silk Road Medical (NASDAQ:SILK) shares fell to $37.91 on Friday, setting a new 52-week low with a shift of up 1.6%.
    • Sharecare (NASDAQ:SHCR) shares reached a new 52-week low of $3.91 on Friday morning, moving down 4.36%.
    • Heliogen (NYSE:HLGN) stock dropped to a yearly low on Friday of $6.95. Shares traded down 10.47%.
    • Velo3D (NYSE:VLD) shares were down 1.98% for the day, having made a 52-week low of $6.32.
    • Archer Aviation (NYSE:ACHR) shares set a new 52-week low of $4.62. The stock traded down 7.24%.
    • Vicarious Surgical (NYSE:RBOT) stock achieved a new 52-week low on Friday morning, hitting $9.11 and moving down 0.22%.
    • Companhia Brasileira (NYSE:CBD) stock achieved a new 52-week low on Friday morning, hitting $3.42 and moving down 0.29%.
    • CEVA (NASDAQ:CEVA) shares were down 1.5% for the day, having made a 52-week low of $39.77.
    • Telos (NASDAQ:TLS) shares set a new 52-week low of $13.54. The stock traded down 1.51%.
    • GoHealth (NASDAQ:GOCO) shares moved down 4.72% on Friday to hit a new 52-week low of $2.58, drifting down 4.72%.
    • PMV Pharmaceuticals (NASDAQ:PMVP) stock set a new 52-week low of $18.33 on Friday, moving down 0.42%.
    • Repare Therapeutics (NASDAQ:RPTX) stock set a new 52-week low of $17.63 on Friday, moving down 4.23%.
    • Cardiovascular Systems (NASDAQ:CSII) stock hit a new 52-week low of $18.27. The stock was down 2.03% on the session.
    • Meta Materials (NASDAQ:MMAT) shares made a new 52-week low of $2.41 on Friday. The stock was up 0.2% for the day.
    • Berkeley Lights (NASDAQ:BLI) shares were up 2.83% for the day, having made a 52-week low of $9.40.
    • Nuvalent (NASDAQ:NUVL) shares hit a yearly low of $13.91. The stock was down 4.98% on the session.
    • Kinnate Biopharma (NASDAQ:KNTE) stock dropped to a yearly low on Friday of $14.74. Shares traded down 3.29%.
    • Nano X Imaging (NASDAQ:NNOX) stock broke to a new 52-week low of $13.31 on Friday. Shares of the company traded down 0.44%.
    • 908 Devices (NASDAQ:MASS) shares moved down 0.44% on Friday to hit a new 52-week low of $20.05, drifting down 0.44%.
    • BioAtla (NASDAQ:BCAB) shares were down 0.16% for the day, having made a 52-week low of $15.43.
    • Decarbonization Plus (NASDAQ:DCRN) stock hit a yearly low of $9.38. The stock was down 0.41% for the day.
    • OraSure Technologies (NASDAQ:OSUR) stock drifted down 1.78% on Friday morning to hit a new 52-week low of $7.61.
    • Phathom Pharmaceuticals (NASDAQ:PHAT) stock drifted up 0.4% on Friday morning to hit a new 52-week low of $17.25.
    • SkyWater Technology (NASDAQ:SKYT) shares made a new 52-week low of $13.03 on Friday. The stock was down 1.04% for the day.
    • Vuzix (NASDAQ:VUZI) stock hit a yearly low of $7.97. The stock was down 1.7% for the day.
    • Hyperfine (NASDAQ:HYPR) shares set a new yearly low of $6.80 this morning. The stock was down 2.86% on the session.
    • BlackSky Technology (NYSE:BKSY) stock drifted up 1.95% on Friday morning to hit a new 52-week low of $3.87.
    • Entrada Therapeutics (NASDAQ:TRDA) shares made a new 52-week low of $11.86 on Friday. The stock was down 5.71% for the day.
    • Shattuck Labs (NASDAQ:STTK) shares moved down 1.19% on Friday to hit a new 52-week low of $7.41, drifting down 1.19%.
    • Esperion Therapeutics (NASDAQ:ESPR) stock drifted up 0.34% on Friday morning to hit a new 52-week low of $4.29.
    • 111 (NASDAQ:YI) shares set a new 52-week low of $2.99. The stock traded up 1.32%.
    • Fluidigm (NASDAQ:FLDM) stock dropped to a yearly low on Friday of $3.21. Shares traded up 0.77%.
    • RxSight (NASDAQ:RXST) stock broke to a new 52-week low of $9.13 on Friday. Shares of the company traded down 1.62%.
    • Luna Innovations (NASDAQ:LUNA) stock hit a yearly low of $7.63. The stock was up 0.45% for the day.
    • CalAmp (NASDAQ:CAMP) shares moved down 1.37% on Friday to hit a new 52-week low of $6.69, drifting down 1.37%.
    • Aligos Therapeutics (NASDAQ:ALGS) shares fell to $4.15 on Friday, setting a new 52-week low with a shift of down 46.75%.
    • ChromaDex (NASDAQ:CDXC) shares set a new yearly low of $3.38 this morning. The stock was down 1.16% on the session.
    • Mogo (NASDAQ:MOGO) shares hit a yearly low of $2.97. The stock was down 0.33% on the session.
    • Humanigen (NASDAQ:HGEN) stock achieved a new 52-week low on Friday morning, hitting $3.06 and moving up 0.8%.
    • Cascadia Acquisition (NASDAQ:CCAI) shares fell to $9.66 on Friday, setting a new 52-week low with a shift of down 0.31%.
    • Helbiz (NASDAQ:HLBZ) shares made a new 52-week low of $5.28 on Friday. The stock was down 0.79% for the day.
    • Beam Global (NASDAQ:BEEM) stock hit a new 52-week low of $16.06. The stock was down 1.08% on the session.
    • Shapeways Hldgs (NYSE:SHPW) stock set a new 52-week low of $3.01 on Friday, moving down 0.66%.
    • Athenex (NASDAQ:ATNX) stock broke to a new 52-week low of $1.30 on Friday. Shares of the company traded 0.0% (flat).
    • Field Trip Health (NASDAQ:FTRP) stock hit a new 52-week low of $2.07. The stock was up 1.96% on the session.
    • O2Micro Intl (NASDAQ:OIIM) shares moved down 0.67% on Friday to hit a new 52-week low of $4.25, drifting down 0.67%.
    • SOC Telemed (NASDAQ:TLMD) stock achieved a new 52-week low on Friday morning, hitting $1.15 and moving down 3.23%.
    • Avalo Therapeutics (NASDAQ:AVTX) stock hit a new 52-week low of $0.98. The stock was down 14.88% on the session.
    • Mullen Automotive (NASDAQ:MULN) shares moved down 1.4% on Friday to hit a new 52-week low of $4.78, drifting down 1.4%.
    • 4d pharma (NASDAQ:LBPS) stock hit $5.01 on Friday morning, setting a new 52-week low for a change of down 4.8%.
    • Aurora Mobile (NASDAQ:JG) stock hit a yearly low of $0.92. The stock was down 3.67% for the day.
    • Applied Therapeutics (NASDAQ:APLT) shares were down 1.62% for the day, having made a 52-week low of $4.20.
    • Ayala Pharmaceuticals (NASDAQ:AYLA) shares hit a yearly low of $7.50. The stock was down 1.9% on the session.
    • Neuronetics (NASDAQ:STIM) stock achieved a new 52-week low on Friday morning, hitting $3.69 and moving down 3.33%.
    • DTFTax-Free Income (NYSE:DTF) shares set a new 52-week low of $14.08. The stock traded down 0.18%.
    • Anixa Biosciences (NASDAQ:ANIX) shares reached a new 52-week low of $2.71 on Friday morning, moving up 3.77%.
    • Ontrak (NASDAQ:OTRK) shares set a new 52-week low of $4.54. The stock traded down 3.15%.
    • Clever Leaves Holdings (NASDAQ:CLVR) stock set a new 52-week low of $2.72 on Friday, moving up 1.45%.
    • Cidara Therapeutics (NASDAQ:CDTX) stock hit $1.06 on Friday morning, setting a new 52-week low for a change of down 4.34%.
    • iSun (NASDAQ:ISUN) stock drifted down 2.14% on Friday morning to hit a new 52-week low of $5.26.
    • Freeline Therapeutics (NASDAQ:FRLN) stock hit a yearly low of $1.71. The stock was down 9.61% for the day.
    • MamaMancini's Holdings (NASDAQ:MMMB) stock dropped to a yearly low on Friday of $1.77. Shares traded down 2.54%.
    • Cocrystal Pharma (NASDAQ:COCP) shares set a new yearly low of $0.59 this morning. The stock was down 4.78% on the session.
    • Imara (NASDAQ:IMRA) shares set a new 52-week low of $2.08. The stock traded down 0.47%.
    • Odonate Therapeutics (NASDAQ:ODT) stock hit a yearly low of $0.85. The stock was down 1.65% for the day.
    • TD Hldgs (NASDAQ:GLG) stock hit a new 52-week low of $0.35. The stock was down 2.07% on the session.
    • E-Home Household Service (NASDAQ:EJH) shares set a new yearly low of $1.27 this morning. The stock was down 0.77% on the session.
    • Clarus Therapeutics Hldgs (NASDAQ:CRXT) stock set a new 52-week low of $1.68 on Friday, moving down 2.79%.
    • Recon Technology (NASDAQ:RCON) shares made a new 52-week low of $1.24 on Friday. The stock was up 3.87% for the day.
    • Enveric Biosciences (NASDAQ:ENVB) stock drifted up 0.6% on Friday morning to hit a new 52-week low of $0.83.
    • Catalyst Biosciences (NASDAQ:CBIO) stock achieved a new 52-week low on Friday morning, hitting $0.84 and moving up 0.16%.
    • Metacrine (NASDAQ:MTCR) stock hit a new 52-week low of $0.57. The stock was up 2.87% on the session.
    • Cuentas (NASDAQ:CUEN) stock achieved a new 52-week low on Friday morning, hitting $1.23 and moving up 0.79%.
    • Siyata Mobile (NASDAQ:SYTA) stock set a new 52-week low of $1.78 on Friday, moving down 43.96%.
    •  

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ACHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHR
    $ALGS
    $ALHC
    $ANIX

    CompanyDatePrice TargetRatingAnalyst
    Alignment Healthcare Inc.
    $ALHC
    4/17/2026$24.00Outperform
    Wolfe Research
    Elanco Animal Health Incorporated
    $ELAN
    4/15/2026$30.00Buy
    Citigroup
    Natera Inc.
    $NTRA
    4/14/2026Outperform
    William Blair
    CAMP4 Therapeutics Corporation
    $CAMP
    4/14/2026$7.00Buy
    Rodman & Renshaw
    Avalo Therapeutics Inc.
    $AVTX
    4/9/2026$48.00Outperform
    Wolfe Research
    Avalo Therapeutics Inc.
    $AVTX
    4/6/2026$52.00Mkt Outperform
    Citizens
    Entrada Therapeutics Inc.
    $TRDA
    4/1/2026Overweight
    Cantor Fitzgerald
    Nuvalent Inc.
    $NUVL
    3/30/2026$116.00Overweight
    Wells Fargo
    More analyst ratings

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wolfe Research initiated coverage on Alignment Healthcare with a new price target

    Wolfe Research initiated coverage of Alignment Healthcare with a rating of Outperform and set a new price target of $24.00

    4/17/26 8:10:24 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Citigroup initiated coverage on Elanco Animal Health with a new price target

    Citigroup initiated coverage of Elanco Animal Health with a rating of Buy and set a new price target of $30.00

    4/15/26 8:08:24 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    William Blair initiated coverage on Natera

    William Blair initiated coverage of Natera with a rating of Outperform

    4/14/26 8:34:48 AM ET
    $NTRA
    Medical Specialities
    Health Care

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Crescent Biopharma Announces Grants of Inducement Awards

    WALTHAM, Mass., April 24, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. ("Crescent" or the "Company") (NASDAQ:CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 12,525 shares of the Company's ordinary shares to two non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the "Inducement Plan"). The options were approved on April 23, 2026 and were material to each employee's acceptan

    4/24/26 4:15:00 PM ET
    $CBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    National Veterinary Associates Appoints Todd S. Young as Chief Financial Officer

    National Veterinary Associates (NVA) announced the appointment of Todd S. Young as Chief Financial Officer, effective May 1, 2026. Young will serve on the company's executive leadership team and report to Chief Executive Officer John Bruno. "I am thrilled to welcome Todd to NVA," said Bruno. "He has spent his career leading world-class finance teams in human and animal healthcare, and his public company experience and deep industry knowledge are exactly what we need as we enter our next phase of growth." Young brings more than 25 years across human and animal healthcare, including more than a decade as a public company CFO. Most recently, he served as CFO of Acadia Healthcare (NASDAQ:AC

    4/24/26 9:00:00 AM ET
    $ACHC
    $ELAN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    SOUTH SAN FRANCISCO, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (NASDAQ:ALGS, "Aligos", "Company")), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company's Board of Directors granted non-qualified stock options to purchase an aggregate of 10,700 shares of the Company's stock (the "Inducement Grant") to newly hired employees on April 22, 2026 (the "Grant Date"), in connection with the commencement of employment. The Inducement Grants were granted pursuant to Aligos' 2024 Inducement Plan (the "Plan") as an induceme

    4/24/26 8:00:00 AM ET
    $ALGS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Former officer Parkinson Christopher Iain

    4 - Vuzix Corp (0001463972) (Issuer)

    4/24/26 6:49:53 PM ET
    $VUZI
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Amendment: Chief Risk & Compl. Officer Hilberg Christopher covered exercise/tax liability with 1,083 shares, decreasing direct ownership by 3% to 39,656 units (SEC Form 4) (withholding obligation)

    4/A - SkyWater Technology, Inc (0001819974) (Issuer)

    4/23/26 5:22:49 PM ET
    $SKYT
    Semiconductors
    Technology

    SEC Form 4 filed by Muniz Thomas Paul

    4 - Archer Aviation Inc. (0001824502) (Issuer)

    4/22/26 8:03:29 PM ET
    $ACHR
    Aerospace
    Industrials

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    SEC Filings

    View All

    SEC Form 425 filed by SkyWater Technology Inc.

    425 - SkyWater Technology, Inc (0001819974) (Subject)

    4/24/26 5:11:46 PM ET
    $SKYT
    Semiconductors
    Technology

    SEC Form 8-K filed by SkyWater Technology Inc.

    8-K - SkyWater Technology, Inc (0001819974) (Filer)

    4/24/26 5:10:39 PM ET
    $SKYT
    Semiconductors
    Technology

    Vuzix Corporation filed SEC Form 8-K: Leadership Update

    8-K - Vuzix Corp (0001463972) (Filer)

    4/24/26 4:30:56 PM ET
    $VUZI
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VOQUEZNA issued to PHATHOM PHARMACEUTICALS INC

    Submission status for PHATHOM PHARMACEUTICALS INC's drug VOQUEZNA (ORIG-1) with active ingredient VONOPRAZAN FUMARATE has changed to 'Approval' on 07/17/2024. Application Category: NDA, Application Number: 218710, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    7/18/24 10:52:01 AM ET
    $PHAT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-16) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:30 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-17) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:37 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Mcgrath Kenneth J bought $66,030 worth of shares (22,021 units at $3.00), increasing direct ownership by 4% to 557,262 units (SEC Form 4)

    4 - ORASURE TECHNOLOGIES INC (0001116463) (Issuer)

    3/16/26 8:01:53 PM ET
    $OSUR
    Medical/Dental Instruments
    Health Care

    President & CEO Eglinton Manner Carrie bought $66,033 worth of shares (22,022 units at $3.00), increasing direct ownership by 1% to 2,158,574 units (SEC Form 4)

    4 - ORASURE TECHNOLOGIES INC (0001116463) (Issuer)

    3/16/26 8:01:38 PM ET
    $OSUR
    Medical/Dental Instruments
    Health Care

    Director Sams Louise S bought $48,360 worth of shares (1,000 units at $48.36), increasing direct ownership by 5% to 20,409 units (SEC Form 4)

    4 - COSTAR GROUP, INC. (0001057352) (Issuer)

    3/9/26 8:00:08 AM ET
    $CSGP
    Real Estate

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Leadership Updates

    Live Leadership Updates

    View All

    National Veterinary Associates Appoints Todd S. Young as Chief Financial Officer

    National Veterinary Associates (NVA) announced the appointment of Todd S. Young as Chief Financial Officer, effective May 1, 2026. Young will serve on the company's executive leadership team and report to Chief Executive Officer John Bruno. "I am thrilled to welcome Todd to NVA," said Bruno. "He has spent his career leading world-class finance teams in human and animal healthcare, and his public company experience and deep industry knowledge are exactly what we need as we enter our next phase of growth." Young brings more than 25 years across human and animal healthcare, including more than a decade as a public company CFO. Most recently, he served as CFO of Acadia Healthcare (NASDAQ:AC

    4/24/26 9:00:00 AM ET
    $ACHC
    $ELAN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations

    PMV Pharmaceuticals Announces Board Chair Transition

    PRINCETON, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (("PMV Pharma" or the "Company", NASDAQ:PMVP), a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53, today announced a leadership transition on its Board of Directors. Laurie Stelzer, who has served as a member of the Board since 2020, has been appointed Chair of the Board, succeeding Rich Heyman, Ph.D., effective at the Company's 2026 Annual Meeting of Stockholders on June 4, 2026 (the "Meeting"). Dr. Heyman's term as a member and Chair of the Board will expire at the Meeting, and Dr. Heyman will not stand for reelection. Ms. Stelzer brings more than 25

    4/22/26 8:00:00 AM ET
    $PMVP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces the appointment of Kola Otitoju as its Chief Business & Strategy Officer, a newly created executive position. Mr. Otitoju will oversee product and corporate strategy, business development, mergers and acquisitions, and partnership initiatives as 908 Devices expands its market presence across public health, safety, and defense-tech applications. Mr. Otitoju brings over 25 years of proven executive leadership in strategy, business development, and P&L management across the medical technology, life sciences, and industrial sectors. Most recently, he served as Senior Vice President of

    4/21/26 5:00:00 PM ET
    $MASS
    Industrial Machinery/Components
    Industrials

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Financials

    Live finance-specific insights

    View All

    Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH

    SAN FRANCISCO, April 23, 2026 /PRNewswire/ -- Bitwise Asset Management, a leading crypto asset manager, today announced the monthly distributions for its suite of Option Income Strategy ETFs: IMST, ICOI, IMRA, IGME, ICRC, and IETH. FundTickerDistribution Per ShareDistribution Rate30-Day SEC YieldReturn of CapitalEx-Date / Record DatePayment Date1-Month Return1-Year ReturnSince InceptionReturn*Bitwise COINOption Income Strategy ETFICOI$0.2544725.40 %0.00 %100.00 %4/24/20264/28/2026-4.73 %-28.24 %-24.19 %Bitwise MARAOption Income Strategy ETFIMRA$0.1476311.25 %0.00 %100.00 %4/24/2

    4/23/26 5:06:00 PM ET
    $IMRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    N-able to Host First Quarter Earnings Conference Call on May 7, 2026

    N-able, Inc. (NYSE:NABL), a global cybersecurity company delivering business resilience, today announced that it will host a conference call to discuss its financial results for the first quarter of 2026 at 8:30 a.m. ET on May 7, 2026. A live webcast of the call will be available on the N-able Investor Relations website at http://investors.n-able.com. A replay of the webcast will be available on a temporary basis shortly after the event. N-able will issue its earnings release highlighting its first quarter results prior to the start of the conference call on May 7, 2026. About N-able N-able protects businesses from evolving cyberthreats. Our AI-powered cybersecurity platform delivers

    4/23/26 4:30:00 PM ET
    $NABL
    Computer Software: Prepackaged Software
    Technology

    Coursera Reports First Quarter 2026 Financial Results

    Delivered first quarter revenue of $196 million, up 9% year-over-year Grew Consumer segment revenue by 10% year-over-year, the fourth consecutive quarter of double-digit growth Added a first quarter record of 7.6 million new registered learners, bringing cumulative total registered learners to 205 million Reaffirmed full year 2026 revenue outlook range of $805 to $815 million Coursera, Inc. (NYSE:COUR), a leading global online learning platform, today announced financial results for its first quarter ended March 31, 2026. A shareholder letter containing additional discussion of the Company's performance and outlook has been posted to the Investor Relations website at investor.c

    4/23/26 4:10:00 PM ET
    $COUR
    $UDMY
    Computer Software: Prepackaged Software
    Technology
    Other Consumer Services
    Real Estate

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Neuronetics Inc.

    SC 13D - Neuronetics, Inc. (0001227636) (Subject)

    12/17/24 9:15:11 PM ET
    $STIM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by PMV Pharmaceuticals Inc.

    SC 13G - PMV Pharmaceuticals, Inc. (0001699382) (Subject)

    12/12/24 12:29:41 PM ET
    $PMVP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Cidara Therapeutics Inc.

    SC 13G - Cidara Therapeutics, Inc. (0001610618) (Subject)

    12/9/24 5:37:15 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Financial Insight: Purchase at Clover Health Investments Corp. on Jun 20

    The recent insider purchase at Clover Health Investments Corp. by Director Garipalli Vivek on June 20, 2024, has caught the attention of investors. Director Garipalli Vivek bought $1,000,426 worth of shares, acquiring 877,567 units at $1.14 per share, as reported in SEC Form 4. This insider purchase stands out among recent insider transactions at Clover Health. Looking at the previous transactions, there have been instances of insiders covering exercise/tax liability by selling shares, resulting in a decrease in their direct ownership percentages. For example, Reynoso Jamie L., Priest Brady Patrick, Toy Andrew, Sharp Aric R, Soares Karen, Chief Technology Officer Wai Conrad, and CEO Reynoso

    6/20/24 6:36:05 PM ET
    $CLOV
    Medical Specialities
    Health Care